ous study has evaluated just how much improvement can be gained by a multicomponent intervention to raise a highintensity organizational model (defined by mandatory intensivist participation for all ICU patients [17] ) to what expert opinion considers optimal organization. One model of such a multicomponent reorganization has been proposed by the American College of Critical Care Medicine of the Society of Critical Care Medicine in its recommendations for best "level I" ICU organization, which includes intensivist staffing, preferably around-theclock, a complete multidisciplinary team, and complete consultative and hospital services support (Table 1) (16).
We hypothesized that a multicomponent intervention would improve clinical outcomes and are the first to evaluate the effect of bringing an ICU to a resource level equivalent to level I. The intervention consisted of a physical relocation of the MICU to new facilities, the institution of 24 hr/day, 7 day/week staffing by a critical care board-certified intensivist, the addition of a full-time clinical pharmacist to the multidisciplinary team, and a change in the respiratory therapist: patient ratio from 1:24 to 1:10. We assess the impact of this intervention on hospital and MICU mortality, 28-day ventilator-free days (VFDs) and sedative use.
MATERIALS AND METHODS
Environment and Intervention. We conducted a single-center, quasiexperimental study (22, 23) The preintervention physician staffing was a high-intensity model (6) in a closed-model ICU (24) staffed by an intensivist Ն8 hrs daily, 7 days/week (25). Staffing was consistent with the recommendations of the Leapfrog Group, an organization founded by a consortium of Fortune 500 companies to provide advice on healthcare (26). Additionally, the MICU was staffed 24 hrs/day by house officers, consisting of one fellow, two residents, and four interns, and overnight call staffed by one resident and one intern. After January 1, 2006, there were also two nurse practitioners staffing the MICU preintervention. The preintervention nursing core consisted of trained critical care nurses, overseen by a qualified nurse manager. The preintervention patient:nurse ratio of 1:1.7 has been associated with improved outcomes (15, 27) and did not change over this period. As part of a large, tertiary academic medical center, the MICU preintervention resources included complete 24-hr laboratory and radiology services. Clinical pharmacists dispensed medication 24-hrs daily but did not routinely round in the MICU, and respiratory therapy (RT) provided around-the-clock care in the MICU. Full consultancy services were available 24 hrs daily. The medical center has been recognized for its quality of care by the Leapfrog Group, which placed it on its honor roll both pre-and postintervention. The decision to expand the ICU was made in response to increased demand for medical critical care, as a part of the move to a new hospital building, and was unrelated to prior clinical performance of the ICU.
This intervention consisted a physical relocation of the MICU to new facilities, the institution of 24 hr/day, 7 day/week staffing by critical care board-certified intensivists, the addition of a full-time clinical pharmacist to the multidisciplinary team, and a change in the respiratory therapist:patient ratio from 1:24 to 1:10. The change in RT staffing was part of a hospital-wide initiative to create a unit-based staffing initiative in all ICUs and to reduce RT staffing vacancies. All patients were staffed at least daily by an attending physician. The daytime staffing of the MICU consisted of two attending physicians, two fellows, four residents, four interns, and four nurse practitioners. There was no change in the scope of the nurse practitioners' duties. The overnight call team consisted of one attending physician, one resident, and one intern. In addition to the clinical pharmacists dispensing medication, a clinical pharmacist evaluated all patients daily during bedside rounds. The role of the respiratory therapists did not change. The medical director of the MICU did not change. The previous MICU was a 10-bed facility, consisting of all single rooms with a mean room size of 179.0 Ϯ 6.1 square feet. The new MICU is a 29-bed facility, with all rooms being single and with mean room square footage of 380.7 Ϯ 39.4. In addition to the stability of nursing staffing ratios over this period, the MICU nursing leadership remained unchanged. There was no change in laboratory, radiology, or consultant services after the intervention, which continued to be fully available 24 hrs daily.
The Institutional Review Board of the University of Maryland Baltimore approved this study with waiver of consent.
Data Sources and Patient Selection. Data were abstracted from the hospital's electronic medical record and administrative record systems. We evaluated 4,107 consecutive patients in the 24 months preintervention and 24months postintervention with first and single admissions on the data file to protect independence of observations and, to a lesser extent, comparability of the clinical courses studied. Patients missing All Patient Refined-Diagnosis-Related Groups codes and International Classification of Diseases, version 9 codes were excluded from analysis, as were patients with coded negative LOS.
Analytic Approach. Our primary outcome variable was mortality, both in-hospital and in-MICU mortality. We also provide comparisons on several other variables of interest. Baseline MICU admission characteristics preand postintervention are compared by using two-sample Student's t tests for continuous variables (28) and comparisons of proportions for categorical variables (29). The MICU, total hospital, pre-MICU hospital, post-MICU LOS, and median per admission total MICU and hospital variable costs before and after intervention were compared with two-sample Student's t tests and Mann-Whitney tests (30). Unadjusted hospital and MICU mortality and 28-day ICU-free days (31) before and after intervention were evaluated by comparison of The effect of the intervention on hospital and MICU mortality was also evaluated by using logistic regression. To assess for confounding effects of patient characteristics on mortality, the analyses were also performed with variables chosen a priori on the basis of previous studies and biological plausibility: Age, gender, race, first-level Agency for Healthcare Research and Quality Clinical Classifications Software 2010 diagnostic category (36, 37), Charlson score (38, 39), for baseline characteristics, and to adjust for severity of illness, admission laboratory values (hemoglobin, white blood cell count, creatinine, sodium, potassium, glucose, and bicarbonate) (40 -45), and the case mix index (CMI) weight, a Maryland state measure based on diagnoses and used to adjust hospital reimbursement for expected resource intensity of treatment. (CMI scores are weighted to a state average of 1.00 [46] ). Each variable was evaluated individually for effect on the association of the intervention with mortality in logistic regression models. The variables that altered the odds ratio (OR) of the intervention by 15% were considered potentially significant confounders (47). The effect of the intervention on MICU, total hospital, pre-MICU hospital, and post-MICU LOS was evaluated with linear regression, with unadjusted and multivariable models.
Additional analyses were performed evaluating the period July 1, 2005 to April 18, 2006, preintervention, and September 5, 2006 to September 4, 2008, postintervention. These dates reflect the earliest availability of pharmacy data preintervention. Sedative and opiate use per MICU patient and per patient prescribed each agent was compared. To assess for any possible effect of seasonal variation, these baseline characteristic and outcomes were also evaluated comparing July 1, 2005 to April 18, 2006 and July 1, 2007 to April 18, 2008.
Analyses were performed using SAS version 9.1.3 (SAS Institute, Cary, NC). We applied the traditional definitions of statistical significance (48).
RESULTS
There were 1,263 patients preintervention and 2,424 patients postintervention for analysis. The proportion of patients with single hospital admissions did not change after the intervention (82.0% vs. 81.8%, p ϭ .92). Within a hospital admission, the rate of MICU readmission was 6.0% preintervention and 9.6% postintervention (p Ͻ .001). Patients admitted after the intervention were similar to those preintervention ( Fig. 1 ). There were no differences in gender, comorbidity (as measured by the Charlson score), or expected intensity of care (as measured by the CMI). After the intervention, patients were less likely to be non-White (53.8% vs. 58.0%, p ϭ .017) and may have been slightly older (54.4 Ϯ 16.4 vs. 53.4 Ϯ 15.9 yrs, p ϭ .066) ( Table 2 ). There were clinically modest changes in the primary diagnosis of patients, with an increase in vascular-related and neoplasm admissions and corresponding modest declines in the relative incidence of other diagnoses. The relative proportion of admission sources did not change (Appendix Table 1 ). the probability of observing an association as strong or stronger than observed, assuming no difference in the distribution of MICU primary diagnoses pre-and postintervention.
Mortality after the multicomponent intervention decreased. All-cause MICU mortality experienced a 19% relative reduction, from 18.4% to 14.9% (p ϭ .006) ( Table 2) , whereas all-cause in-hospital mortality had a 16% relative reduction, from 25.8% to 21.7% (p ϭ .005). In stratified analysis, MICU mortality among ever-ventilated patients was reduced from 31.6% to 28.7% (p ϭ .210) and among never-ventilated patients was reduced from 5.6% to 4.2% (p ϭ .177), although these reductions did not meet statistical significance.
The diminished likelihood of death after the intervention remained after adjustment for patient baseline and clinical variables ( Table 3 ). Although none of these variables was found to change significantly the point estimate of OR of death, to assess for potential additive effect as well as to insure control for all clinical variables, we included them in the multivariable explanatory models. Our results for MICU mortality were consistent both in the unadjusted model (OR ϭ 0.78, 95% confidence interval: 0.65-0.93, p ϭ .007) and in the complete multivariable model with adjustments for patient age, gender, race, primary diagnosis category, Charlson score, MICU admission laboratory values, and CMI weight (OR ϭ 0.74, 95% confidence interval: 0.62-0.88, p ϭ .003). The OR for in-hospital mortality after the intervention was 0.80 (95% confidence interval: 0.68 -0.93, p ϭ .005) in the unadjusted model and 0.74 (95% confidence interval: 0.62-0.88, p ϭ .001) in the complete explanatory model. A sensitivity analysis found these results robust (Appendix Table 2 ). The increase in MICU LOS remained significant after adjustment, and the lack of change in hospital LOS was consistent after adjustment. In subgroup analysis, these reductions were consistent in patients receiving renal replacement therapy, vasopressor therapy, mechanical ventilation, and with diagnoses of severe sepsis and septic shock (Appendix Table 3 ).
Whereas median MICU LOS increased from 2.4 (1.1-5.2) days to 2.7 (1.3-5.9) days (p ϭ .009), there was no change in total hospital LOS 8. 3 $27,843.30) (p ϭ .005). Rank sum testing showed no differences in the composite ranking of death and MICU LOS and reductions in composite ranking of death and hospital LOS (Appendix Table 4 ).
The intervention decreased sedation usage. Due to limitations in preintervention pharmacy data, these outcomes were evaluated by using a 10-month preintervention epoch compared with the 2-yr postintervention period. The characteristics of these patient groups are consistent with the 2-yr pre-and postperiod (Appendix Table 5 ). Identical 10-month intervals (from July 1, 2005 to April 18, 2006 and July 1, 2007 to April 18, 2008) were also compared to evaluate baseline characteristics and outcomes; these were similar to the 10-month pre-and 24-month postvalues (Appendix Table 6 ). There were substantial decreases in the mean daily doses of sedative medications for patients receiving these medications, as well as for total daily doses expressed as an average for all MICU patients (Table 4 ). These decreases were greatest for fentanyl and lorazepam, with no compensating increase in the use of propofol. The proportion of patients receiving midazolam increased but with reduced daily dosing after the intervention. The proportion of patients receiving haloperidol increased after the intervention.
We chose 365-day time periods preand postintervention to prevent results occurring from seasonal variation. Significant changes in MICU and hospital mortality and LOS were found comparing the periods of 4/19/05-4/18/06 and 9/5/06 -9/4/07. We used 2-year epochs to increase statistical power and lessen the likelihood that any change detected was from year-toyear variation. The statistical comparison of 1-yr characteristics and outcomes are shown in Appendix Table 7 .
DISCUSSION
In an already high functioning tertiary care ICU with a high-intensity staffing model and multiple other best practices, a reorganization of care was associated with substantial improvements in outcome, with 19% relative reduction in MICU mortality and a 16% relative reduction in hospital mortality, accompanied by a 1-day increase in 28-day VFDs in ever-ventilated patients. Additionally, there was a significant decrease in the use of sedative medications. This is the first study to find a survival benefit associated with improvements to an organization-ally mature, Leapfrog-adherent MICU. Although these results may not be achievable by all ICUs at all points, they do suggest that the magnitude of feasible improvements in patient outcomes may be greater than is sometimes assumed.
Given the high volumes and high mortality associated with critical care services in the United States, our findings suggest that investing resources to bring select ICUs to the equivalent of full level I organization may have a profound impact. It has previously been estimated that approximately 53,000 lives would be saved yearly, if all urban hospitals implemented the ICU physician staffing recommendations of the Leapfrog Group (49, 50). Based on our findings, if these urban hospitals also adopted all the improvements seen in our MICU postintervention and had equivalent changes, an additional 10,400 lives would be saved each year. Among the 528,000 patients admitted yearly to urban ICUs already with intensivist staffing, there would be another 10,000 lives saved yearly. Thus, the adoption of level I organization in the United States could save a total of 20,000 additional lives each year in urban ICUs. While the Leapfrog guidelines provide a starting point for potential gains in survival, this suggests that further reductions in mortality may be possible with greater resources and further reorganization.
Critical care consumes substantial resources and its cost continues to increase (51, 52). With the realization of its expense, an impetus has emerged to improve care, which has resulted in guidelines and recommendations from a number of organizations (16, 25). There is often pessimism about the possibility of substantial improvements in outcomes in much of medical practice. However, our results provide evidence in the United States that accord with the results of the recent United Kingdom experience: That with increased resources expenditure-as evidenced by our greater postintervention MICU and total hospital variable costs-substantial improvements in patient outcomes are possible from the reorganization of critical care services. In the United Kingdom, the National Health Service increased spending on critical care by Ͼ40%, embarking on a multicomponent intervention consisting of a 35% increase in ICU beds, the creation of clinical networks, and adoption of clinical protocols. This resulted in an 11.3% decrease in adjusted ICU mortality and a 13.4% decrease in hos-pital mortality. These changes were deemed "highly cost-effective" by stringent U.K. standards (53).
Because the intervention in our MICU consisted of multiple components, it is difficult to elucidate the relative contribution of each discrete change. However, literature exists to suggest that each individual organizational change may have provided independent benefit. A highintensity ICU staffing model consisting of 24 hr/day, 7 day/week intensivist staffing has been recommended (17) and has been associated with increased compliance with clinical protocols while reducing LOS (21), eliminating disparities arising from time of admission (54 -59), and possibly reducing mortality (20, 60). The presence of a pharmacist in the ICU has been associated with reduced mortality, adverse events, infections, and drug charges (61-65). The effect of changing the respiratory therapist:patient ratio has not been previously evaluated; expert opinion suggests that the optimal ratio of patients to respiratory care practitioners is between 9:1 and 11:1 (66). This may facilitate increased use of patient-oriented, respiratory care-driven protocols (67-70). Overall, care by a multidisciplinary team has been found to be associated with reduced mortality (71). An around-the-clock physician likely maximizes the potential benefit of such a multidisciplinary team, especially one meeting the highest American College of Critical Care Medicine standards.
With the organizational changes, the MICU meets all guidelines set by the American College of Critical Care Medicine for the Society of Critical Care Medicine for the designation of a level I critical care setting (16). These include closed-model ICU staffed by intensivists, with the 24-hr coverage described as "ideal." As per these guidelines, the multidisciplinary team of the MICU includes a nurse manager, trained critical care nursing, RT services, and critical care pharmacists. As a tertiary academic medical center, the availability of subspecialty consultants and diagnostic and laboratory resources also meet these guidelines. The reductions in mortality achieved through the full adoption of level Iequivalent critical care lends further weight to calls for regionalization of critical care in the United States (72-74). These recommendations are based on studies showing that outcomes are improved for critically ill patients in high-volume clinical centers (1, 3, 4, (75) (76) (77) . Our findings suggest that increased resource allocation on designated level I centers will improve care and may facilitate a system that transfers critically ill patients, improving survival (73).
There are several limitations to consider. Because a randomized clinical trial was not feasible, a quasiexperimental design was utilized. Multiple control variables were used to adjust for potential changes in the patient population preand postintervention, with consistent results. However, the possibility of residual confounding or unobserved case mix changes, that our results may have occurred secondary to admitting patients who were not as ill, cannot be definitively excluded. Significant changes in patient diagnoses occurred after the intervention. Data were unavailable for the accurate calculation and use of common measures of acuity such as Acute Physiology and Chronic Health Evaluation (APACHE) scoring, although we used multiple, validated variables including Agency for Healthcare Research and Quality Clinical Classifications Software categories, CMI scores, and admission laboratory values. To assess the possible impact of residual confounding, a sensitivity analysis was performed, and it revealed that the reduction in MICU and hospital mortality was consistent in multiple models. We found an increase in MICU LOS after the intervention. While the etiology of this increase cannot be ascertained, the reduction in mortality may have resulted in patients who would have previously died with short LOS now surviving with commensurately longer LOS. Rank sum testing of the composite end point of MICU mortality and LOS pre-and postintervention were equivalent, suggesting that mortality was traded for LOS. In the rank sum testing of composite hospital mortality and LOS, all ranks were improved, consistent with the reductions in the component end points of mortality and hospital LOS (78).
In considering our outcomes, it should be noted that, as a single-center study, these results may not be generalizable to all ICUs. It is unlikely that untargeted expenditures of additional resources in an ICU would result in patient improvements. Instead, reorganization and intensification may need to be customized to the particular ICU and hospital environment. Finally, it is essential to note that cost-effectiveness analyses (necessary from the distinct perspectives of the hospital, payers, and from society as a whole) are beyond the scope of the present manuscript but are essential to considering the policy implications of this finding.
CONCLUSIONS
Widespread variation in quality and outcomes is well documented in critical care. Our results demonstrate that even in a high functioning MICU already meeting national recommendations such as those of the Leapfrog group, targeted reorganization and investment has been associated with further, substantial improvements in patient outcomes. A multicomponent intervention including 24-hr intensivist staffing, the addition of a dedicated critical care pharmacist, increased RT staffing, and larger, more modern patient rooms was able to result in a 19% reduction in MICU mortality, a 16% reduction in hospital mortality, and a 5% increase in VFDs. Reductions in sedative use were also obtained. Hospital LOS did not change, although MICU LOS increased. By establishing an even higher standard of ICU staffing and care, it may be possible to effect even greater increases in survival than previously estimated, with potentially even greater overall cost effectiveness than previously estimated with traditional, high-intensity physician staffing (79).
Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. 
APPENDIX
Sensitivity Tests, Particularly for Residual Confounding. Residual confounding is a major challenge to the potential validity of the study. We have conducted several analyses to assess the possibility that changes other than the intervention might account for the changes in mortality we documented. Of particular concern is the possibility of changes in severity of illness of patients. Our results appear to be robust.
In Appendix Table 1 , we show that there was no significant change in the Admission Source for patients between the pre-and postintervention period.
To further assess the plausible extent of residual confounding, recall that our basic adjusted model included age, gender, race, primary diagnosis (categorical variable), Charlson Score (a measure of comorbidity), and the CMI (a measure of expected resource intensity). The model with adjustment for laboratory value included the values on MICU admission of glucose, sodium, potassium, bicarbonate, and creatinine, as well as the white blood cell count and hematocrit; all laboratory values were made into categorical variables as per the APACHE II Acute Physiology score cutoffs. We performed a sensitivity analysis by examining the absolute difference in mortality in unadjusted models and in models with progressively greater adjustment. These mortality differences were based on the predicted probabilities from the logistic regression model, implemented by using the STATA (STATA, Col-lege Station, TX) "adjust" command. (Identical results were obtained from predicted probabilities in SAS [SAS, Cary, NC].) If there was substantial confounding of the MICU reorganizations with severity of illness, we would expect to see smaller and smaller differences in mortality between pre-and postintervention periods as we included better and better risk adjustment. The results of this analysis are in Appendix Table 2 .
In fact, the mortality difference was unchanged by adjustment for confounding. If anything, the association with hospital mortality becomes greater with more extensive controls.
There are two possible interpretations for this. The first is that our association is relatively independent of confounding by severity of illness. The alternative interpretation is that there exists some form of severity of illness that was much more common before the MICU reorganization than afterward and that this form of severity of illness is uncorrelated with all the covariates included in the fully adjusted model. This second potential explanation is highly implausible. Our fully adjusted model includes primary diagnosis, comorbid disease, age, and other demographicsall key components of major severity of illness scores such as APACHE. Further, our results were further unchanged by including presentation laboratory values for sodium, potassium, white blood cell count, bicarbonate, glucose, creatinine, and hemoglobin. Although not a full APACHE score, our results were remarkably robust to inclusion of most of the domains of the APACHE score and therefore likely to be quite robust to unmeasured domains of severity of illness to the extent that those unmeasured domains are correlated with our many measured domains.
To extend this analysis further, we replicated our model in several pertinent subgroups, as documented in Appendix Table 3 . Here we see that all point estimates show a consistent pattern of lower mortality after we frankly acknowledge there is some variation in the particular odds ratio for the association between the intervention and mortality. In some cases the SEs have increased such that the point estimate in a subgroup is not, on its own, statistically significant. (Note, of course, that in no case is the point estimate statistically significantly different from the overall group point estimate, either.) However, there is a clear consistent direction of effect.
Appendix Tables 4 -7 document other sensitivity tests referred to in the main text. MICU, medical intensive care unit; CMI, case mix index. a p values were obtained from tests of comparison of proportions/two-sample Student's t test; b first-level Agency for Healthcare Research and Quality Clinical Classifications Software 2010 diagnostic category; c the probability of observing an association as strong or stronger than observed, assuming no difference in the distribution of MICU primary diagnoses pre-and postintervention. 
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